Naturally activates energy, without caffeine*
These multifaceted actions contribute to both improved glycemic control and weight reduction, which has made this drug class particularly valuable for patients with type 2 diabetes who are overweight or obese
"Not for a company to say: 'Oh, this is how I know we're going to make money
While a causal relationship remains inconclusive (patients with T2D and obesity have other pancreatitis risk factors), prudence dictates avoiding these drugs in patients with a history of pancreatitis or at least using with caution
Check packaging for Novo Nordisk branding, holographic seals, lot numbers, and expiration dates
Adults in both groups used insulin and oral diabetes medications during the study